These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33486440)

  • 1. Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study.
    Tosoni A; Gatto L; Franceschi E; Di Nunno V; Lodi R; Mura A; Di Battista M; Bartolini S; Brandes AA
    Eur J Cancer; 2021 Mar; 145():171-178. PubMed ID: 33486440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
    Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
    Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intersection of race and social determinants of health on clinical outcome of glioblastoma patients.
    Asfaw ZK; Hernandez-Marquez GC; Naik A; Young T; Vega Perez R; Bickell N; Germano IM
    J Neurosurg; 2024 Sep; 141(3):614-623. PubMed ID: 38579343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study.
    Estevez-Ordonez D; Abdelrashid M; Coffee E; Laskay NMB; Atchley TJ; Chkheidze R; Fiveash JB; Markert JM; Lobbous M; Maveal BM; Burt Nabors L
    Cancer; 2023 Oct; 129(19):3010-3022. PubMed ID: 37246417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients.
    Rigamonti A; Imbesi F; Silvani A; Gaviani P; Agostoni E; Porcu L; De Simone I; Torri V; Salmaggi A
    J Neurol Sci; 2018 Jul; 390():14-19. PubMed ID: 29801876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Survival in Turkish Patients with Primary Glioblastoma.
    Bilgin E; Duman BB; Altintas S; Cil T; Gezercan Y; Okten AI
    Turk Neurosurg; 2021; 31(4):641-653. PubMed ID: 33759174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
    Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
    Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
    Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
    Rhome R; Fisher R; Hormigo A; Parikh RR
    J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    Ryu JY; Min KL; Chang MJ
    PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
    Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013.
    Zreik J; Moinuddin FM; Yolcu YU; Alvi MA; Chaichana KL; Quinones-Hinojosa A; Bydon M
    J Neurooncol; 2020 May; 148(1):69-79. PubMed ID: 32363470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
    Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
    Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
    Roh TH; Park HH; Kang SG; Moon JH; Kim EH; Hong CK; Ahn SS; Choi HJ; Cho J; Kim SH; Lee SK; Kim DS; Kim SH; Suh CO; Lee KS; Chang JH
    Medicine (Baltimore); 2017 Jul; 96(27):e7422. PubMed ID: 28682902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.